| # | Drug | Count |
|---|---|---|
| 0 | ESOMEPRAZOLE MAGNESIUM | 69 |
| 1 | APIXABAN | 68 |
| 2 | ALBUTEROL SULFATE | 67 |
| 3 | ESOMEPRAZOLE | 62 |
| 4 | METFORMIN | 61 |
| 5 | FAMOTIDINE | 59 |
| 6 | MONTELUKAST | 57 |
| 7 | LORATADINE | 54 |
| 8 | LORATADINE ORAL | 53 |
| 9 | ANASTROZOLE | 52 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CEFADROXIL | 9 | 0.0044 |
| 1 | PROMETHAZINE HYDROCHLORIDE | 49 | 0.0026 |
| 2 | ESOMEPRAZOLE MAGNESIUM DIHYDRATE | 34 | 0.0023 |
| 3 | INSULIN GLARGINE-YFGN | 50 | 0.0022 |
| 4 | ANASTROZOLE TABLETS | 41 | 0.0019 |
| 5 | ANASTROZOLE | 52 | 0.0014 |
| 6 | ROSUVASTATIN CALCIUM | 36 | 0.0012 |
| 7 | APIXABAN | 68 | 0.0010 |
| 8 | FEBUXOSTAT TABLETS 40 MG | 10 | 0.0010 |
| 9 | MOXIFLOXACIN HYDROCHLORIDE | 16 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 154 |
| 1 | Proton Pump Inhibitor [EPC] | 100 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 70 |
| 3 | Factor Xa Inhibitor [EPC] | 67 |
| 4 | Insulin Analog [EPC] | 66 |
| 5 | Histamine-2 Receptor Antagonist [EPC] | 59 |
| 6 | Aromatase Inhibitor [EPC] | 52 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 50 |
| 8 | Thalidomide Analog [EPC] | 42 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 40 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Photoactivated Radical Generator [EPC] | 1 | 0.0078 |
| 1 | Leukotriene Receptor Antagonist [EPC] | 36 | 0.0012 |
| 2 | Interferon gamma [EPC] | 1 | 0.0007 |
| 3 | Cephalosporin Antibacterial [EPC] | 5 | 0.0006 |
| 4 | CD38-directed Cytolytic Antibody [EPC] | 3 | 0.0005 |
| 5 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 2 | 0.0005 |
| 6 | Antihypoglycemic Agent [EPC] | 2 | 0.0005 |
| 7 | Aromatase Inhibitor [EPC] | 52 | 0.0005 |
| 8 | beta Lactamase Inhibitor [EPC] | 2 | 0.0004 |
| 9 | Histamine-2 Receptor Antagonist [EPC] | 59 | 0.0004 |